Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/9503
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kovala-Demertzi, D. | en |
dc.contributor.author | Staninska, M. | en |
dc.contributor.author | Garcia-Santos, I. | en |
dc.contributor.author | Castineiras, A. | en |
dc.contributor.author | Demertzis, M. A. | en |
dc.date.accessioned | 2015-11-24T16:49:34Z | - |
dc.date.available | 2015-11-24T16:49:34Z | - |
dc.identifier.issn | 0162-0134 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/9503 | - |
dc.rights | Default Licence | - |
dc.subject | metal complexes | en |
dc.subject | meclofenamic acid | en |
dc.subject | crystal structures | en |
dc.subject | spectroscopic studies | en |
dc.subject | antineoplastic activity | en |
dc.subject | sod activity | en |
dc.subject | nonsteroidal antiinflammatory drugs | en |
dc.subject | assay | en |
dc.subject | agents | en |
dc.title | Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity | en |
heal.type | journalArticle | - |
heal.type.en | Journal article | en |
heal.type.el | Άρθρο Περιοδικού | el |
heal.identifier.primary | DOI 10.1016/j.jinorgbio.2011.05.025 | - |
heal.identifier.secondary | <Go to ISI>://000294085500010 | - |
heal.identifier.secondary | http://ac.els-cdn.com/S0162013411001401/1-s2.0-S0162013411001401-main.pdf?_tid=332449108575ed10df26df7a82bc928d&acdnat=1333028832_d6acba594a165dc65b1e8fc02493551e | - |
heal.language | en | - |
heal.access | campus | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
heal.publicationDate | 2011 | - |
heal.abstract | Some new complexes of meclofenamic acid (N-(2,6-dichloro-m-tolyl)anthranilic acid), Hmeclo (1), with potentially interesting biological activities are described. Complexes [Mn(meclo)(2)] (2), [Cu(meclo)(2)(H(2)O)(2)] (3), [Zn(meclo)(2)(H(2)O)(2)] (4) and [Cd(meclo)(2)(H(2)O)(2)] (5) were prepared and structurally characterized by means of vibrational, electronic and (1)H and (13)C NMR spectroscopies. The crystal structure of complexes [Cu(4)(meclo)(6)(OH)(2)(DMSO)(2)]center dot 2DMSO (3a) and [Cd(meclo)(2)(DMSO)(3)] (5a) have been determined by X-ray crystallography. Complex (3a) is a centrosymmetric tetramer built up around the planar cyclic Cu(2)(OH)(2) unit Complex 5a is mononuclear seven-coordinated complex with the meclofenamato ligand behaving as a bidentate deprotonated chelating ligand. Intra and intermolecular hydrogen bonds stabilize these two structures, while the crystal packing is determined by pi-pi and C-H--pi interactions. Meclofenamic acid and its metal complexes have been evaluated for antiproliferative activity in vitro against the cells of three human cancer cell lines, MCF-7 (breast cancer cell line), T24 (bladder cancer cell line), and A-549 (non-small cell lung carcinoma), and a mouse fibroblast L-929 cell line. Complex 5 exhibits the highest selectivity against MCF-7 and 4 shows the highest selectivity against T-24. Complexes 2-5 were found to be more potent cytotoxic agents against T-24 and complex 5 against MCF-7 cancer cell lines than the prevalent benchmark metallodrug, cis-platin. The superoxide dismutase activity was measured by the Fridovich test which showed that complex [Cu(meclo)(2)(H(2)O)(2)] is a good superoxide scavenger. (C) 2011 Elsevier Inc. All rights reserved. | en |
heal.journalName | J Inorg Biochem | en |
heal.journalType | peer reviewed | - |
heal.fullTextAvailability | TRUE | - |
Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Kovala-Demertzi-2011-Synthesis, crystal s.pdf | 628.35 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License